Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/26/24 18:44 | 8/23/24 | KRBP | Health | BioPrd | Biological Products, (No Diag | Bersani Pietro | TX | DO | CEO | 2 | P.m | 27 | 2.84 | 0 | 9 | 7 | 142 | D | ||||||||||||||
8/21/24 16:29 | 8/19/24 | KRBP | Health | BioPrd | Biological Products, (No Diag | Hungerford Brian | TX | O | CFO | 4 | P.m | 18 | 2.26 | 0 | 8 | 14 | 65 | D | ||||||||||||||
6/13/24 18:32 | 6/12/24 | KRBP | Health | BioPrd | Biological Products, (No Diag | Misajon Pamela | TX | D | 2 | P | 10 | 3.10 | 0 | 3 | 13 | 29 | D | |||||||||||||||
6/12/24 16:37 | 6/11/24 | KRBP | Health | BioPrd | Biological Products, (No Diag | Nagel Michael | TX | D | 1 | P | 3 | 3.33 | 0 | 1 | 2 | 43 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |